Japan Obesity Treatment Market Size & Outlook, 2025-2030
Related Markets
Japan obesity treatment market highlights
- The Japan obesity treatment market generated a revenue of USD 309.4 million in 2024 and is expected to reach USD 849.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 18.5% from 2025 to 2030.
- In terms of segment, lipase inhibitors (orlistat) was the largest revenue generating drug class in 2024.
- Other Drug Class is the most lucrative drug class segment registering the fastest growth during the forecast period.
Obesity treatment market data book summary
| Market revenue in 2024 | USD 309.4 million |
| Market revenue in 2030 | USD 849.1 million |
| Growth rate | 18.5% (CAGR from 2025 to 2030) |
| Largest segment | Lipase inhibitors (orlistat) |
| Fastest growing segment | Other Drug Class |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | GLP-1 Receptor Agonists, Lipase Inhibitors (Orlistat), Appetite Suppressants (Phentermine, Lorcaserin), Other Drug Class |
Other key industry trends
- In terms of revenue, Japan accounted for 1.9% of the global obesity treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan obesity treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 326.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Obesity Treatment Market Scope
Obesity Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| B Braun Melsungen AG | View profile | - | - | - |
| CryoLife, Inc. | View profile | - | - | - |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| HyperBranch Medical Technology | View profile | 11-50 | Durham, North Carolina, United States, North America | http://hyperbranch.com |
| Cohera Medical | View profile | 1-10 | Pittsburgh, Pennsylvania, United States, North America | http://www.coheramedical.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Japan obesity treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to obesity treatment market will help companies and investors design strategic landscapes.
Lipase inhibitors (orlistat) was the largest segment with a revenue share of 61.02% in 2024. Horizon Databook has segmented the Japan obesity treatment market based on glp-1 receptor agonists, lipase inhibitors (orlistat), appetite suppressants (phentermine, lorcaserin), other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Japan obesity treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan obesity treatment market databook
-
Our clientele includes a mix of obesity treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan obesity treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan obesity treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan Drug Class - Obesity Treatment Market size, 2024 - 2030 (US$M)
Japan Obesity Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
